학술논문
A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16)
Document Type
Article
Author
Source
In: British Journal of Haematology . (British Journal of Haematology, August 2023, 202(4):801-811)
Subject
Language
English
ISSN
13652141
00071048
00071048